AzTrials
AzTrials

Acute StrokeNCT05454397

A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

An observational study of Acute Stroke, run by Nanfang Hospital, Southern Medical University at 34 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Stroke is the leading cause of premature death and disability, and early recognition and treatment of dysphagia is fundamental to stroke management. Early and full tube feeding in the acute phase of stroke helps to address nutritional problems resulting from dysphagia and impaired consciousness and helps to reduce… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Stroke
How many people
2,000 participants
Where
34 sitesChina
Study dates
1 Sep 2022to 15 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Newly admitted stroke patients admitted to the neurology unit, ≥18 years of age, within 7 days of onset, expected survival >3 months, expected neurology stay 7-10 days, and at risk of malnutrition (MUST ≥2 points) or at nutritional risk (NRS2002 ≥3 points). Patients' age, sex, hospital, hospitalization number, height, primary diagnosis on admission, and previous underlying disease were collected.

Who may be able to join

  • Newly admitted stroke patients admitted to neurology, age ≥18 years, within 7 days of onset, expected survival >3 months (i.e., not end-stage), expected neurology stay 7-10 days;
  • At risk of malnutrition (MUST ≥ 2 points) or at nutritional risk (NRS2002 ≥ 3 points), sign an informed notice.

Who cannot join

  • Transferred during treatment, contraindications to nutritional therapy (e.g., hemodynamic instability, gastrointestinal bleeding (bleeding >100 ml), other nutritional studies, pregnancy.

Trial locations and contacts

34 sites in 1 country.

JinYu Chen, M.D. contact

+8615876578154

568344684@qq.com

34 sites in 1 country

China34 sites, 34 recruiting
  • Dongfang Hospital of Beijing University of Chinese Medicine

    Beijing, Beijing Municipality

    Baoxin Chen, MD, 13581546499

    Recruiting
  • The First Hospital of Jilin University

    Changchun, Jilin

    Xin Sun, MD, 13596116866

    Recruiting
  • Xiangya Hospital Central South University

    Changsha, Hunan

    Fangfang Bi, MD, 13739064027

    Recruiting
  • Chongqing People's Hospital

    Chongqing, Sichuang

    Chengqun Wang, MD, 15998950878

    Recruiting
  • The First Afilliated Hospital of Fujian Medical University

    Fuzhou, Fujian

    Zhiqiang Wang, MD, 13805059300

    Recruiting
  • Ganzhou People'S Hospital

    Ganzhou, Jiangxi

    Chaohui Lai, MD, 13879729792

    Recruiting
  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong

    JinYu Chen, MD, 568344684@qq.com

    Suyue Pan, M.D., Ph.D.

    Recruiting
  • Red Cross Hospital of Hangzhou

    Hangzhou, Zhejiang

    Mingming Ma, MD, 13738132607‬

    Recruiting
  • Zhejiang Province Xiaoshan Hospital

    Hanzhou, Zhejiang

    Kai Fang, MD, 18967168308

    Recruiting
  • The second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang

    Lihua Wang, MD, 13100881600

    Recruiting
  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui

    Yajuan Hu, MD, 13956912105

    Recruiting
  • The First People'S Hospital of Jiashan

    Jiaxing, Zhejiang

    Yingshuai Shi, MD, 18358364799

    Recruiting
  • Qilu Hospital of Shandong University

    Jinan, Shandong

    Qinzhou Wang, MD, 18560085523

    Recruiting
  • Affiliated Hospital of Jining Medical Hospital

    Jining, Shandong

    Shaoying Wu, MD, 18678766806

    Recruiting
  • Kaifeng Central Hospital

    Kaifeng, Henan

    Yan Zhao, MD, 15137884148

    Recruiting
  • The First People'S Hospital of Kunshan

    Kunshan, Jiangsu

    Yan Zhang, MD, 13962638897

    Recruiting
  • Linyi People'S Hospital

    Linyi, Shandong

    Guangying Wang, MD, 13695395899

    Recruiting
  • Nanjing Zijin Hospital

    Nanjing, Jiangsu

    Changbao Wang, MD, 13770722709

    Recruiting
  • Zhongda Hospital Southeast Universtiy

    Nanjing, Jiangsu

    Hui Jiao, MD, 1581881150

    Recruiting
  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi

    Zhijian Liang, MD, 13737944579

    Recruiting
  • Qilu Hospital of Shandong University(Qingdao)

    Qingdao, Shandong

    Jijun Teng, MD, 18661806108

    Recruiting
  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong

    Cuiping Zhao, MD, 18561810336

    Recruiting
  • The second Affiliated Hospital of Suzhou University

    Suzhou, Jiangsu

    Weidong Hu, MD, 1351003701

    Recruiting
  • The First People'S Hospital of Wenling

    Wenling, Zhejiang

    Haibo Cai, MD, 13905565806

    Recruiting
  • The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU

    Wenzhou, Zhejiang

    Beilei Hu, 15858515599

    Recruiting
  • Wenzhou Hospital of Chinese Medicine

    Wenzhou, Zhejiang

    Ling Chen, MD, 13868403777

    Recruiting
  • Tongji Hospital of Tongji Medical College of HUST

    Wuhan, Hubei

    Furong Wang, MD, 18627126298

    Recruiting
  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi’an, Shanxi

    Chen Chen, MD, 13363954570

    Recruiting
  • Xi'an Encephalopathy of Traditional Chinese Medicine Hospital

    Xi’an, Shanxi

    Bingcan Yan, 13379236669

    Recruiting
  • Zhongshan Hospital Xiamen University

    Xiamen, Fujian

    Lihong Su, MD, 18060486879

    Recruiting
  • Yancheng Third People's Hospital

    Yancheng, Jiangsu

    Lijuan Wu, MD, 13912569779

    Recruiting
  • Yantai Yuhuangding Hospital

    Yantai, Shandong

    Hong Liu, MD, 13964528128

    Recruiting
  • Fujian Province Zhangzhou Hospital

    Zhengzhou, Fujian

    Bailing Chen, MD, 15892014859

    Recruiting
  • Henan Provincial People'S Hospital

    Zhengzhou, Henan

    Yong Yao, MD, 13837136563

    Recruiting

Other trials in China

About this study

Stroke is the leading cause of premature death and disability, and early recognition and treatment of dysphagia is fundamental to stroke management. Early and full tube feeding in the acute phase of stroke helps to address nutritional problems resulting from dysphagia and impaired consciousness and helps to reduce morbidity and mortality and poor outcomes. Current guidelines for acute stroke management do not address the goal of tube feeding of enteral nutrition for energy and protein. In the treatment of acute stroke, there is a strong global focus on pharmacological thrombolysis or mechanical thrombolysis, with nutritional interventions being a less explored topic. Real-world evidence on large samples, feeding attainment and outcomes, and nutrition in the acute phase of stroke is lacking in China . The aim of this study was to understand the current status of nutritional therapy in stroke hospitalization in neurology and its impact on prognosis nationwide, and to improve the standardized management process of enteral nutrition therapy in the acute phase of stroke.

Read the detailed description

Malnutrition is a common geriatric syndrome with a disproportionate incidence in geriatric and neurology inpatients. In recent years, national nutritional surveys of geriatric inpatients have shown that about 2/3 of geriatric inpatients have nutritional problems; only half of neurology inpatients at high risk receive nutritional support, and inadequate nutrition exacerbates primary disease, increases complications, makes hospital stays longer, and ultimately affects patient survival outcomes.

To increase comprehensive and up-to-date research on the current status of nutritional therapy in geriatric and neurology inpatients, and to lay the foundation for future standardized treatment and standardized management, we conducted a nationwide survey on the current status of nutritional risk screening and treatment in geriatric and neurology inpatients. The aim is to raise the level of clinicians' awareness of malnutrition and nutritional risk in hospitalized patients, standardize clinical practice, and properly implement nutritional support to improve patients' clinical outcomes.

Conditions
Acute Stroke
Being tested
Observational study, no intervention
Keywords
Stroke; Dysphagia;Nutrition management;
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observational study, no interventionOther

    Observational study, no intervention

Study groups in NCT05454397
Study groupRoleWhat they receive
case groupPatients with acute stroke with nutritional risk
Receives: Other: Observational study, no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nutrition implementation rate

    Proportion of patients hospitalized for stroke who were given nutritional support

    Measured: The first day of admission; the seventh day of admission; the day before discharge.

  2. Nutrition compliance rate of stroke inpatients

    Percentage of patients hospitalized for stroke whose nutritional indicators and nutritional status met the guidelines after being given nutritional support

    Measured: The first day of admission; the seventh day of admission; the day before discharge.

Secondary outcomes (4)
  1. 30-day post-discharge mortality

    Proportion of enrolled patients who died 30 days after discharge from the hospital

    Measured: 30-day post-discharge

  2. Infection rate

    Proportion of enrolled patients with pulmonary infection 30 days after discharge from hospital.

    Measured: 30-day post-discharge

  3. Readmission rate

    Proportion of patients enrolled who were readmitted for various reasons 30 days after discharge.

    Measured: 30-day post-discharge

  4. Functional prognosis

    Functional prognosis of the enrolled patients, such as life skills, motor and sensory functions, cognitive functions and swallowing functions.

    Measured: 30-day post-discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2022
  2. Study start1 Sep 2022 (estimated)
  3. Primary completion15 Oct 2022 (estimated)
  4. Study completion15 Oct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05454397
Sponsor's protocol ID
NFEC-2020-234
Status last verified
Oct 2021
First submitted
1 Jul 2022
Last updated
12 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Stroke, run by Nanfang Hospital, Southern Medical University at 34 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 34 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact JinYu Chen, M.D. (+8615876578154, 568344684@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nutrition implementation rate (time frame: The first day of admission; the seventh day of admission; the day before discharge.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in